SCHEDULE 13G/A: First Manhattan Co. Discloses 4.25% Passive Stake in PAVmed Inc.

First Manhattan Co. LLC has filed an amended Schedule 13G, reporting a 4.25% beneficial ownership stake in PAVmed Inc.'s common stock as of March 31, 2025.

Summary

• First Manhattan Co. LLC, a Delaware-based investment adviser, reported beneficial ownership of 714,100 shares of PAVmed Inc. common stock.
• This ownership represents 4.25% of PAVmed Inc.'s common stock outstanding.
• The filing indicates that First Manhattan Co. LLC holds 700,000 shares with sole voting and sole dispositive power.
• An additional 14,100 shares are held with shared voting and shared dispositive power.
• The shares were acquired and are held in the ordinary course of business, explicitly stating they are not for the purpose of changing or influencing control of PAVmed Inc.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a routine disclosure of a passive stake by an institutional investor, which can be seen as a vote of confidence, but it contains no new operational or financial information about the company itself.

Positives

• A significant institutional investor, First Manhattan Co. LLC, maintains a substantial stake in PAVmed Inc., which could be interpreted as a vote of confidence in the company's long-term prospects.
• The filing explicitly states the shares are held in the ordinary course of business and not for control purposes, suggesting a passive, investment-oriented position rather than an activist one.

Negatives

• The document, being a beneficial ownership filing, does not contain negative financial or operational information about PAVmed Inc. itself.

Risks

• The document does not detail specific risks related to PAVmed Inc.'s operations or financial health, as its purpose is solely to disclose beneficial ownership.

Future Outlook

NA

Industry Context

This filing indicates continued institutional interest in the healthcare/medical device sector, specifically in PAVmed Inc., from a prominent investment adviser. Such passive stakes are common and reflect portfolio diversification or long-term investment strategies.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which may influence investor sentiment and perception of the company's stability.

Key Dates

Keywords

PAVmed Inc., First Manhattan Co. LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing